ExodusPoint Capital Management’s Arbor Realty Trust ABR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-84,774
Closed -$1.26M 1634
2023
Q2
$1.26M Sell
84,774
-95,828
-53% -$1.19M 0.01% 1008
2023
Q1
$2.08M Buy
+180,602
New +$2.5M 0.02% 861
2022
Q4
Sell
-119,186
Closed -$1.37M 1580
2022
Q3
$1.37M Sell
119,186
-47,601
-29% -$701K 0.02% 965
2022
Q2
$2.19M Sell
166,787
-29,997
-15% -$482K 0.03% 742
2022
Q1
$3.36M Sell
196,784
-287,403
-59% -$5.05M 0.04% 548
2021
Q4
$8.87M Buy
484,187
+109,812
+29% +$2.06M 0.09% 257
2021
Q3
$6.94M Buy
374,375
+146,350
+64% +$2.64M 0.09% 291
2021
Q2
$4.06M Buy
228,025
+180,000
+375% +$3.17M 0.04% 425
2021
Q1
$764K Buy
+48,025
New +$742K 0.01% 1080
2020
Q4
Sell
-108,757
Closed -$1.25M 1899
2020
Q3
$1.25M Buy
+108,757
New +$1.14M 0.02% 595
2020
Q1
Sell
-163,353
Closed -$2.34M 1034
2019
Q4
$2.34M Buy
163,353
+129,342
+380% +$1.84M 0.04% 305
2019
Q3
$446K Buy
+34,011
New +$425K 0.02% 711

Other funds holding ABR

ExodusPoint Capital Management's ABR Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of Arbor Realty Trust (ABR) in Q3 2023, closing a stake of 84,774 shares — an estimated $1.26M sold.

ExodusPoint Capital Management first reported a position in ABR in Q3 2019 and held it in 12 quarters. The position peaked at $8.87M in Q4 2021. 297 funds tracked by Wall St. Rank hold ABR as of Q3 2023.

  • ExodusPoint Capital Management reported no remaining Arbor Realty Trust position as of Q3 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 84,774 Arbor Realty Trust shares in Q3 2023, an estimated $1.26M.
  • ExodusPoint Capital Management first reported a position in Arbor Realty Trust in Q3 2019 and held it in 12 quarters.
  • ExodusPoint Capital Management's Arbor Realty Trust position peaked at $8.87M in Q4 2021.
  • 297 funds tracked by Wall St. Rank held Arbor Realty Trust as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.